FDA Scientists Investigating How 3-D Imaging Can Transform Medical Screening Devices

Tuesday, October 7, 2014
The Washington Post reports that scientists at the Food and Drug Administration are “investigating how 3-D imaging — the technology used to create more realistic animations in video games and movies — could transform medical screening devices.” In particular, researchers “are focused on early breast cancer detection; in a process known as tomosynthesis, new screening machines take low-dose X-rays from various angles, overlaying them to produce a 3-D rendering of a patient’s breast.” The Post explains, “Traditional mammograms create a 2-D image, and cannot show cancers hidden by overlapping tissue, according to the FDA, which last week released a consumer update (10/6) on the new technology to coincide with the start of Breast Cancer Awareness month.”

Federal Study Says Physicians Need More Information About Breast Cancer Imaging Options

Friday, October 3, 2014
Congressional Quarterly reports that the Agency for Healthcare Research and Quality (AHRQ) in conjunction with the Pacific Northwest Evidence-Based Practice Center issued a report saying that American doctors need more information about the relative benefits and drawbacks of different imaging technology available to them when diagnosing and treating breast cancer. Physicians do not always understand when to use different technologies, including magnetic resonance imaging, computed tomography, positron emission tomography, PET/CT, and bone scans. CQ describes AHRQ as “a lesser known agency within the Department of Health and Human Services that funds work helping doctors choose among competing treatments and approaches to illness.”